30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Jounce Therapeutics Inc (JNCE)

Track

Stock chart
Ticker: JNCE Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
MURRAY RICHARD /CA/
1 sale — total 72,572 USD
Planned sale 4 Apr 2023
Value US$4,381,396.80 | Price 146.85 | Shares 57,238
Buy 14 Mar 2023
Value US$1,850,521.51 | Price 17.10 | Shares 29,335
Buy 13 Mar 2023
Value US$65,306.79 | Price 0.99 | Shares 65,701
Sale 10 Jan 2023
Value US$10,283.84 | Price 1.12 | Shares 9,182
Sale 10 Jan 2023
Value US$5,741.12 | Price 1.12 | Shares 5,126
Sale 10 Jan 2023
Value US$27,864.48 | Price 1.12 | Shares 24,879
Sale 10 Jan 2023
Value US$8,714.72 | Price 1.12 | Shares 7,781
Sale 9 Jan 2023
Value US$8,197.20 | Price 1.10 | Shares 7,452
Sale 9 Jan 2023
Value US$4,574.90 | Price 1.10 | Shares 4,159
Proposed sale 9 Jan 2023
Value US$11,400.00 | Price 1.14 | Shares 10,000
Sale 9 Jan 2023
Value US$22,210.10 | Price 1.10 | Shares 20,191
Proposed sale 9 Jan 2023
Value US$51,300.00 | Price 1.14 | Shares 45,000
Sale 9 Jan 2023
Value US$6,946.50 | Price 1.10 | Shares 6,315
Proposed sale 9 Jan 2023
Value US$17,100.00 | Price 1.14 | Shares 15,000
Sale 10 Jan 2022
Value US$54,676.30 | Price 6.65 | Shares 8,222
Sale 10 Jan 2022
Value US$35,763.70 | Price 6.65 | Shares 5,378
Sale 10 Jan 2022
Value US$159,094.60 | Price 6.65 | Shares 23,924
Sale 10 Jan 2022
Value US$41,263.25 | Price 6.65 | Shares 6,205
Sale 7 Jan 2022
Value US$33,543.50 | Price 7.30 | Shares 4,595
Sale 7 Jan 2022
Value US$21,936.50 | Price 7.30 | Shares 3,005
Sale 7 Jan 2022
Value US$97,601.00 | Price 7.30 | Shares 13,370
Sale 7 Jan 2022
Value US$25,316.40 | Price 7.30 | Shares 3,468
Sale 12 Nov 2021
Value US$15,922,000.00 | Price 8.38 | Shares 1,900,000
Sale 12 Nov 2021
Value US$0.00 | Price 0.00 | Shares 0
Sale 25 May 2021
Value US$4,420,160.00 | Price 8.00 | Shares 552,520
Planned sale 15 Apr 2021
Value US$2,000.00 | Price 10.00 | Shares 200
Planned sale 15 Mar 2021
Value US$2,560.00 | Price 12.80 | Shares 200
Sale 1 Mar 2021
Value US$0.00 | Price 0.00 | Shares 0
Sale 1 Mar 2021
Value US$17,037,500.00 | Price 11.75 | Shares 1,450,000
Planned sale 16 Feb 2021
Value US$2,356.00 | Price 11.78 | Shares 200
Planned sale 22 Jan 2021
Value US$215,100.00 | Price 11.95 | Shares 18,000
Planned sale 21 Jan 2021
Value US$404,227.08 | Price 12.06 | Shares 33,518
Planned sale 21 Jan 2021
Value US$2,222.00 | Price 11.11 | Shares 200
Planned sale 21 Jan 2021
Value US$45,588.00 | Price 12.00 | Shares 3,799
Planned sale 20 Jan 2021
Value US$100,300.00 | Price 10.03 | Shares 10,000
Planned sale 20 Jan 2021
Value US$194,898.03 | Price 12.03 | Shares 16,201
Planned sale 20 Jan 2021
Value US$78,065.00 | Price 12.01 | Shares 6,500
Planned sale 20 Jan 2021
Value US$18,000.00 | Price 12.00 | Shares 1,500
Planned sale 20 Jan 2021
Value US$198,443.28 | Price 12.04 | Shares 16,482
Planned sale 19 Jan 2021
Value US$383,600.00 | Price 9.59 | Shares 40,000
Planned sale 15 Jan 2021
Value US$256,200.00 | Price 8.54 | Shares 30,000
Sale 8 Jan 2021
Value US$23,380.00 | Price 7.00 | Shares 3,340
Sale 8 Jan 2021
Value US$82,712.00 | Price 7.00 | Shares 11,816
Sale 8 Jan 2021
Value US$21,910.00 | Price 7.00 | Shares 3,130
Sale 8 Jan 2021
Value US$19,922.00 | Price 7.00 | Shares 2,846
Sale 7 Jan 2021
Value US$18,231.72 | Price 6.76 | Shares 2,697
Sale 7 Jan 2021
Value US$68,837.08 | Price 6.76 | Shares 10,183
Sale 7 Jan 2021
Value US$19,462.04 | Price 6.76 | Shares 2,879
Sale 7 Jan 2021
Value US$16,575.52 | Price 6.76 | Shares 2,452
Sale 19 Nov 2020
Value US$0.00 | Price 0.00 | Shares 0
Sale 19 Nov 2020
Value US$105,075.00 | Price 7.01 | Shares 15,000
Sale 17 Nov 2020
Value US$108,772.50 | Price 7.25 | Shares 15,000
Sale 17 Nov 2020
Value US$0.00 | Price 0.00 | Shares 0
Planned sale 15 Sep 2020
Value US$52,500.00 | Price 10.50 | Shares 5,000
Planned sale 15 Sep 2020
Value US$47,500.00 | Price 9.50 | Shares 5,000
Planned sale 1 Sep 2020
Value US$58,032.00 | Price 8.06 | Shares 7,200
Sale 18 Aug 2020
Value US$3,504.24 | Price 4.71 | Shares 744
Sale 18 Aug 2020
Value US$3,504.24 | Price 4.71 | Shares 744
Sale 17 Aug 2020
Value US$2,206.44 | Price 4.86 | Shares 454
Sale 17 Aug 2020
Value US$2,206.44 | Price 4.86 | Shares 454
Sale 17 Aug 2020
Value US$2,206.44 | Price 4.86 | Shares 454
Sale 14 Aug 2020
Value US$3,504.24 | Price 4.71 | Shares 744
Sale 14 Aug 2020
Value US$4,565.76 | Price 4.64 | Shares 984
Sale 14 Aug 2020
Value US$4,565.76 | Price 4.64 | Shares 984
Sale 14 Aug 2020
Value US$4,565.76 | Price 4.64 | Shares 984
Sale 7 Jan 2020
Value US$20,414.72 | Price 7.78 | Shares 2,624
Sale 7 Jan 2020
Value US$55,627.00 | Price 7.78 | Shares 7,150
Sale 7 Jan 2020
Value US$20,414.72 | Price 7.78 | Shares 2,624
Sale 7 Jan 2020
Value US$20,414.72 | Price 7.78 | Shares 2,624
Planned sale 6 Jan 2020
Value US$12,165.00 | Price 8.11 | Shares 1,500
Planned sale 23 Dec 2019
Value US$334,800.00 | Price 8.37 | Shares 40,000
Sale 16 Aug 2019
Value US$3,990.56 | Price 3.92 | Shares 1,018
Sale 16 Aug 2019
Value US$3,990.56 | Price 3.92 | Shares 1,018
Sale 16 Aug 2019
Value US$3,990.56 | Price 3.92 | Shares 1,018
Sale 15 Aug 2019
Value US$2,592.00 | Price 4.00 | Shares 648
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-04-06 2023-04-04 PlS Planned sale
MURRAY RICHARD /CA/
Non-Executive Director
57,238 -33.9%
146.85
US$4,381,397 		57,238 -33.9% 146.85 US$4,381,397
2023-03-14 2023-03-14 B Purchase
3.3
TANG KEVIN C
Large shareholder
29,335 +32.4%
17.10
US$1,850,522 		29,335 +32.4% 17.10 US$1,850,522
2023-03-14 2023-03-13 B Purchase
3.3
TANG KEVIN C
Large shareholder
16,806 -9.0%
76.76
US$4,181,609 		16,806 -9.0% 76.76 US$4,181,609
2023-01-11 2023-01-10 S Sale
1.9
Cole Hugh M

Chief Operating Officer

Officer
9,182 -7.7%
1.12
US$10,284 		9,182 -7.7% 1.12 US$10,284
2023-01-11 2023-01-10 S Sale
Trehu Elizabeth

Chief Medical Officer

Officer
5,126 -4.7%
1.12
US$5,741 		5,126 -4.7% 1.12 US$5,741
2023-01-11 2023-01-10 S Sale
MURRAY RICHARD /CA/

CEO and President

Executive Director
24,879 -9.8%
1.12
US$27,864 		24,879 -9.8% 1.12 US$27,864
2023-01-11 2023-01-10 S Sale
Drapkin Kimberlee C

CFO and Treasurer

Officer
7,781 -10.5%
1.12
US$8,715 		7,781 -10.5% 1.12 US$8,715
2023-01-11 2023-01-09 S Sale
1.9
Cole Hugh M

Chief Operating Officer

Officer
7,452 -5.9%
1.10
US$8,197 		7,452 -5.9% 1.10 US$8,197
2023-01-11 2023-01-09 S Sale
Trehu Elizabeth

Chief Medical Officer

Officer
4,159 -3.7%
1.10
US$4,575 		4,159 -3.7% 1.10 US$4,575
2023-01-11 2023-01-09 S Sale
MURRAY RICHARD /CA/

CEO and President

Executive Director
20,191 -7.4%
1.10
US$22,210 		20,191 -7.4% 1.10 US$22,210
2023-01-11 2023-01-09 S Sale
Drapkin Kimberlee C

CFO and Treasurer

Officer
6,315 -7.9%
1.10
US$6,946 		6,315 -7.9% 1.10 US$6,946
2023-01-09 2023-01-09 PrS Proposed sale
Trehu Elizabeth

Officer

Officer
10,000
1.14
US$11,400 		10,000 1.14 US$11,400
2023-01-09 2023-01-09 PrS Proposed sale
Drapkin Kimberlee C

Officer

Officer
15,000
1.14
US$17,100 		15,000 1.14 US$17,100
2023-01-09 2023-01-09 PrS Proposed sale
MURRAY RICHARD /CA/

Officer; Director

Executive Director
45,000
1.14
US$51,300 		45,000 1.14 US$51,300
2022-01-11 2022-01-10 S Sale
Drapkin Kimberlee C

CFO and Treasurer

Officer
8,222 -13.5%
6.65
US$54,676 		8,222 -13.5% 6.65 US$54,676
2022-01-11 2022-01-10 S Sale
Trehu Elizabeth

Chief Medical Officer

Officer
5,378 -5.9%
6.65
US$35,764 		5,378 -5.9% 6.65 US$35,764
2022-01-11 2022-01-10 S Sale
MURRAY RICHARD /CA/

CEO and President

Executive Director
23,924 -11.4%
6.65
US$159,095 		23,924 -11.4% 6.65 US$159,095
2022-01-11 2022-01-10 S Sale
1.9
Cole Hugh M

Chief Business Officer

Officer
6,205 -8.8%
6.65
US$41,263 		6,205 -8.8% 6.65 US$41,263
2022-01-11 2022-01-07 S Sale
Drapkin Kimberlee C

CFO and Treasurer

Officer
4,595 -7.0%
7.30
US$33,544 		4,595 -7.0% 7.30 US$33,544
2022-01-11 2022-01-07 S Sale
Trehu Elizabeth

Chief Medical Officer

Officer
3,005 -3.2%
7.30
US$21,936 		3,005 -3.2% 7.30 US$21,936
2022-01-11 2022-01-07 S Sale
MURRAY RICHARD /CA/

CEO and President

Executive Director
13,370 -6.0%
7.30
US$97,601 		13,370 -6.0% 7.30 US$97,601
2022-01-11 2022-01-07 S Sale
1.9
Cole Hugh M

Chief Business Officer

Officer
3,468 -4.7%
7.30
US$25,316 		3,468 -4.7% 7.30 US$25,316
2021-11-16 2021-11-12 S Sale
3.4
Third Rock Ventures III, L.P.
Large shareholder
1,900,000 -62.3%
8.38
US$15,922,000 		1,900,000 -62.3% 8.38 US$15,922,000
2021-11-16 2021-11-12 S Sale
Pfeffer Cary
Non-Executive Director
0
0.00
US$0 		0 0.00 US$0
2021-05-27 2021-05-25 S Sale
3.0
Third Rock Ventures II, L.P.
Large shareholder
552,520 -8.5%
8.00
US$4,420,160 		552,520 -8.5% 8.00 US$4,420,160
2021-04-16 2021-04-15 PlS Planned sale
Higgons John Duncan
Non-Executive Director
200 -2.0%
10.00
US$2,000 		200 -2.0% 10.00 US$2,000
2021-03-17 2021-03-15 PlS Planned sale
Higgons John Duncan
Non-Executive Director
200 -2.0%
12.80
US$2,560 		200 -2.0% 12.80 US$2,560
2021-03-03 2021-03-01 S Sale
Pfeffer Cary
Non-Executive Director
0
0.00
US$0 		0 0.00 US$0
2021-03-03 2021-03-01 S Sale
3.0
Third Rock Ventures II, L.P.
Large shareholder
1,450,000 -15.8%
11.75
US$17,037,500 		1,450,000 -15.8% 11.75 US$17,037,500
2021-02-18 2021-02-16 PlS Planned sale
Higgons John Duncan
Non-Executive Director
200 -1.9%
11.78
US$2,356 		200 -1.9% 11.78 US$2,356
2021-01-25 2021-01-22 PlS Planned sale
1.9
Cole Hugh M

Chief Business Officer

Officer
18,000 -27.6%
11.95
US$215,100 		18,000 -27.6% 11.95 US$215,100
2021-01-25 2021-01-21 PlS Planned sale
MURRAY RICHARD /CA/

CEO and President

Executive Director
33,518 -19.3%
12.06
US$404,227 		33,518 -19.3% 12.06 US$404,227
2021-01-22 2021-01-21 PlS Planned sale
Higgons John Duncan
Non-Executive Director
200 -1.9%
11.11
US$2,222 		200 -1.9% 11.11 US$2,222
2021-01-22 2021-01-21 PlS Planned sale
Drapkin Kimberlee C

CFO and Treasurer

Officer
3,799 -8.1%
12.00
US$45,588 		3,799 -8.1% 12.00 US$45,588
2021-01-22 2021-01-20 PlS Planned sale
Drapkin Kimberlee C

CFO and Treasurer

Officer
10,000 -18.8%
10.03
US$100,300 		10,000 -18.8% 10.03 US$100,300
2021-01-22 2021-01-20 PlS Planned sale
Drapkin Kimberlee C

CFO and Treasurer

Officer
16,201 -23.4%
12.03
US$194,898 		16,201 -23.4% 12.03 US$194,898
2021-01-22 2021-01-20 PlS Planned sale
Trehu Elizabeth

Chief Medical Officer

Officer
6,500 -8.4%
12.01
US$78,065 		6,500 -8.4% 12.01 US$78,065
2021-01-22 2021-01-20 PlS Planned sale
Higgons John Duncan
Non-Executive Director
1,500 -12.5%
12.00
US$18,000 		1,500 -12.5% 12.00 US$18,000
2021-01-20 2021-01-20 PlS Planned sale
MURRAY RICHARD /CA/

CEO and President

Executive Director
16,482 -10.5%
12.04
US$198,443 		16,482 -10.5% 12.04 US$198,443
2021-01-20 2021-01-19 PlS Planned sale
MURRAY RICHARD /CA/

CEO and President

Executive Director
40,000 -22.2%
9.59
US$383,600 		40,000 -22.2% 9.59 US$383,600
2021-01-20 2021-01-15 PlS Planned sale
MURRAY RICHARD /CA/

CEO and President

Executive Director
30,000 -17.6%
8.54
US$256,200 		30,000 -17.6% 8.54 US$256,200
2021-01-11 2021-01-08 S Sale
1.9
Cole Hugh M

Chief Business Officer

Officer
3,340 -5.7%
7.00
US$23,380 		3,340 -5.7% 7.00 US$23,380
2021-01-11 2021-01-08 S Sale
MURRAY RICHARD /CA/

CEO and President

Executive Director
11,816 -7.8%
7.00
US$82,712 		11,816 -7.8% 7.00 US$82,712
2021-01-11 2021-01-08 S Sale
Drapkin Kimberlee C

CFO and Treasurer

Officer
3,130 -5.3%
7.00
US$21,910 		3,130 -5.3% 7.00 US$21,910
2021-01-11 2021-01-08 S Sale
Trehu Elizabeth

Chief Medical Officer

Officer
2,846 -3.8%
7.00
US$19,922 		2,846 -3.8% 7.00 US$19,922
2021-01-11 2021-01-07 S Sale
Drapkin Kimberlee C

CFO and Treasurer

Officer
2,697 -4.4%
6.76
US$18,232 		2,697 -4.4% 6.76 US$18,232
2021-01-11 2021-01-07 S Sale
MURRAY RICHARD /CA/

CEO and President

Executive Director
10,183 -6.3%
6.76
US$68,837 		10,183 -6.3% 6.76 US$68,837
2021-01-11 2021-01-07 S Sale
1.9
Cole Hugh M

Chief Business Officer

Officer
2,879 -4.7%
6.76
US$19,462 		2,879 -4.7% 6.76 US$19,462
2021-01-11 2021-01-07 S Sale
Trehu Elizabeth

Chief Medical Officer

Officer
2,452 -3.2%
6.76
US$16,576 		2,452 -3.2% 6.76 US$16,576
2020-11-23 2020-11-19 S Sale
Pfeffer Cary
Non-Executive Director
0
0.00
US$0 		0 0.00 US$0
2020-11-23 2020-11-19 S Sale
3.0
Third Rock Ventures II, L.P.
Large shareholder
15,000 -0.2%
7.01
US$105,075 		15,000 -0.2% 7.01 US$105,075
2020-11-19 2020-11-17 S Sale
3.0
Third Rock Ventures II, L.P.
Large shareholder
15,000 -0.2%
7.25
US$108,772 		15,000 -0.2% 7.25 US$108,772
2020-11-19 2020-11-17 S Sale
Pfeffer Cary
Non-Executive Director
0
0.00
US$0 		0 0.00 US$0
2020-09-16 2020-09-15 PlS Planned sale
Duncan Barbara Gayle
Non-Executive Director
5,000 -100.0%
10.50
US$52,500 		5,000 -100.0% 10.50 US$52,500
2020-09-16 2020-09-15 PlS Planned sale
Duncan Barbara Gayle
Non-Executive Director
5,000 -50.0%
9.50
US$47,500 		5,000 -50.0% 9.50 US$47,500
2020-09-02 2020-09-01 PlS Planned sale
Drapkin Kimberlee C

CFO and Treasurer

Officer
7,200 -10.4%
8.06
US$58,032 		7,200 -10.4% 8.06 US$58,032
2020-08-18 2020-08-18 S Sale
1.9
Cole Hugh M

Chief Business Officer

Officer
744 -1.2%
4.71
US$3,504 		744 -1.2% 4.71 US$3,504
2020-08-18 2020-08-18 S Sale
Drapkin Kimberlee C

CFO and Treasurer

Officer
744 -1.1%
4.71
US$3,504 		744 -1.1% 4.71 US$3,504
2020-08-18 2020-08-17 S Sale
1.9
Cole Hugh M

Chief Business Officer

Officer
454 -0.7%
4.86
US$2,206 		454 -0.7% 4.86 US$2,206
2020-08-18 2020-08-17 S Sale
Drapkin Kimberlee C

CFO and Treasurer

Officer
454 -0.6%
4.86
US$2,206 		454 -0.6% 4.86 US$2,206
2020-08-18 2020-08-17 S Sale
Trehu Elizabeth

Chief Medical Officer

Officer
454 -0.6%
4.86
US$2,206 		454 -0.6% 4.86 US$2,206
2020-08-18 2020-08-14 S Sale
Trehu Elizabeth

Chief Medical Officer

Officer
744 -1.0%
4.71
US$3,504 		744 -1.0% 4.71 US$3,504
2020-08-18 2020-08-14 S Sale
Drapkin Kimberlee C

CFO and Treasurer

Officer
984 -1.4%
4.64
US$4,566 		984 -1.4% 4.64 US$4,566
2020-08-18 2020-08-14 S Sale
Trehu Elizabeth

Chief Medical Officer

Officer
984 -1.2%
4.64
US$4,566 		984 -1.2% 4.64 US$4,566
2020-08-18 2020-08-14 S Sale
1.9
Cole Hugh M

Chief Business Officer

Officer
984 -1.5%
4.64
US$4,566 		984 -1.5% 4.64 US$4,566
2020-01-10 2020-01-07 S Sale
Trehu Elizabeth

Chief Medical Officer
2,624 -4.4%
7.78
US$20,415 		2,624 -4.4% 7.78 US$20,415
2020-01-10 2020-01-07 S Sale
MURRAY RICHARD /CA/

CEO and President

Executive Director
7,150 -7.6%
7.78
US$55,627 		7,150 -7.6% 7.78 US$55,627
2020-01-10 2020-01-07 S Sale
Drapkin Kimberlee C

CFO and Treasurer
2,624 -5.6%
7.78
US$20,415 		2,624 -5.6% 7.78 US$20,415
2020-01-10 2020-01-07 S Sale
1.9
Cole Hugh M

Chief Business Officer
2,624 -7.2%
7.78
US$20,415 		2,624 -7.2% 7.78 US$20,415
2020-01-08 2020-01-06 PlS Planned sale
Higgons John Duncan
1,500 -11.1%
8.11
US$12,165 		1,500 -11.1% 8.11 US$12,165
2019-12-26 2019-12-23 PlS Planned sale MURRAY RICHARD /CA/

CEO and President

Executive Director
40,000 -29.7%
8.37
US$334,800 		40,000 -29.7% 8.37 US$334,800
2019-08-16 2019-08-16 S Sale Drapkin Kimberlee C

CFO and Treasurer

Officer
1,018 -2.1%
3.92
US$3,991 		1,018 -2.1% 3.92 US$3,991
2019-08-16 2019-08-16 S Sale Cole Hugh M

Chief Business Officer

Officer
1,018 -2.7%
3.92
US$3,991 		1,018 -2.7% 3.92 US$3,991
2019-08-16 2019-08-16 S Sale Trehu Elizabeth

Chief Medical Officer

Officer
1,018 -1.7%
3.92
US$3,991 		1,018 -1.7% 3.92 US$3,991
2019-08-16 2019-08-15 S Sale
Drapkin Kimberlee C

CFO and Treasurer

Officer
648 -1.3%
4.00
US$2,592 		648 -1.3% 4.00 US$2,592
Explore more

More insider trading research around Jounce Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America